Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
KDIGO made 12 recommendations for managing diabetes with CKD..
Ann Intern Med. 174(3), JC26.
(2021). Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?.
Curr Pharm Des. 13(2), 229-39.
(2007). Gestational diabetes mellitus: why screen and how to diagnose..
Hippokratia. 15(2), 187-8.
(2011). Focal nodular hyperplasia of the liver in a patient with primary aldosteronism..
J Gastroenterol Hepatol. 19(4), 480-1.
(2004). A comparison of the aldosterone-blocking agents eplerenone and spironolactone..
Clin Cardiol. 32(4), 230.
(2009). Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism..
Expert Opin Pharmacother. 9(4), 509-15.
(2008). The unilateral measurement of blood pressure may mask the diagnosis or delay the effective treatment of hypertension..
Angiology. 56(5), 565-9.
(2005). The relationship between the sympathetic nervous system and the renin-angiotensin system in renovascular hypertension..
Acta Cardiol. 49(5), 425-34.
(1994). Implementation of guidelines for the management of arterial hypertension. The impulsion study..
Open Cardiovasc Med J. 3, 26-34.
(2009). IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer..
Anticancer Res. 39(6), 2811-2819.
(2019). Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin's lymphoma..
Ann Hematol. 84(5), 343-6.
(2005). Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial..
BMJ Open. 6(11), e012185.
(2016). GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis..
Diabetes Res Clin Pract. 174, 108737.
(2021). Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas..
Endocr Relat Cancer. 15(3), 693-700.
(2008). Lack of an association between angiotensin-converting enzyme gene insertion/deletion polymorphism and ischaemic stroke..
Eur Neurol. 51(3), 148-52.
(2004). Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy..
Core Evid. 12, 1-10.
(2017). Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism..
Nephrol Dial Transplant. 22(1), 293.
(2007). Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?.
Angiology. 60(4), 397-402.
(2009). Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.
Therapeutic Advances in Drug Safety. 7(2), 36 - 38.
(2016). On the Origin of Dolabriferol: Total Synthesis via Its Putative Contiguous Precursor..
Org Lett. 18(15), 3794-7.
(2016). Plasma B-type natriuretic peptide is related to left ventricular mass in hypertensive patients..
Eur Heart J. 25(21), 1967.
(2004). Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients..
Neurol Res. 32(3), 326-31.
(2010). Gestational diabetes mellitus: why screen and how to diagnose..
Hippokratia. 14(3), 151-4.
(2010). The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?.
Expert Opin Ther Targets. 11(2), 191-205.
(2007). Serum uric acid as an independent predictor of early death after acute stroke..
Circ J. 71(7), 1120-7.
(2007).